Information Provided By:
Fly News Breaks for December 9, 2016
AGN
Dec 9, 2016 | 06:47 EDT
After hosting meetings with management, Citi analyst Liav Abraham sees a favorable setup for Allergan shares heading into 2017. The analyst highlights the lowered revenue expectations following the recent Q3 results, ongoing "strong" performance from key franchises as well as pipeline and M&A optionality. Abraham keeps a Buy rating on the shares.
News For AGN From the Last 2 Days
There are no results for your query AGN